Pharmaceutical Chemistry I, Institute of Pharmacy, University of Bonn, Brühler Straße 7, 53119 Bonn, Germany.
ChemMedChem. 2012 Feb 6;7(2):326-33. doi: 10.1002/cmdc.201100405. Epub 2011 Dec 7.
Tridegin, a 66-mer peptide isolated from the leech Haementeria ghilianii, is a potent inhibitor of the coagulation factor XIIIa. This paper describes the chemical synthesis of tridegin by two different strategies--solid-phase assembly and native chemical ligation--both followed by oxidation in solution phase. Tridegin and truncated analogues were examined for their activity and revealed a particular importance of the C-terminal region of the parent peptide. Based on these studies a minimal sequence required for factor XIIIa inhibition could be identified. Our data revealed that the glutamine residue at position 52 (Q52) of tridegin most likely binds to the active site of factor XIIIa and was therefore suggested to react with the enzyme. The function of the N-terminal region is also discussed, as the isolated C-terminal segment of tridegin lost its inhibitory activity rapidly in the presence of factor XIIIa, whereas this was not the case for the full-length inhibitor.
从医蛭 Haementeria ghilianii 中分离得到的 66 肽 Tridegin 是凝血因子 XIIIa 的有效抑制剂。本文描述了通过两种不同策略——固相组装和天然化学连接——以及随后在溶液相中进行氧化来合成 Tridegin。研究了 Tridegin 和截短类似物的活性,揭示了亲本肽的 C 末端区域的特殊重要性。基于这些研究,可以确定抑制因子 XIIIa 所需的最小序列。我们的数据表明,Tridegin 位置 52 的谷氨酰胺残基(Q52)很可能与因子 XIIIa 的活性位点结合,因此推测它与酶发生反应。还讨论了 N 末端区域的功能,因为在因子 XIIIa 存在下,Tridegin 的分离的 C 末端片段迅速失去其抑制活性,而全长抑制剂则不是这种情况。